IXensor Co., Ltd.
6734
Rank in Stocks
#29839
iXensor Co., Ltd. operates a cutting-edge technological platform that... iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest Blood Glucose Monitoring System and PixoTest POCT System assist in managing long-term conditions. Women's Health: The Eveline Smart Fertility System and Eveline Care Telehealth Platform provide tools for fertility tracking and remote care. Infectious Diseases: Offerings such as the PixoTest COVID-19 Rapid Antigen Test facilitate rapid detection and management. Additionally, iXensor provides supporting digital infrastructure, including the PixoHealth Pass Admin app and its corresponding web portal. Established in Taipei, Taiwan, in 2012, the company is a pioneer in mobile-driven diagnostic solutions.
Share Price
$0.16004341
Last synced: 2026-11-10
Market Cap
$6.73M
Change (1 day)
0.96%
Change (1 year)
-30.14%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade IXensor Co., Ltd. (6734)
Category
Healthcare
EPS for IXensor Co., Ltd. (6734)
EPS as of June 2026 TTM: $-0.04
According to IXensor Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.04, an increase over its 2024 EPS of $-0.06.
EPS history for IXensor Co., Ltd. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | -6.50% |
| 2025 | $-0.04 | -30.08% |
| 2024 | $-0.06 | 66.67% |
| 2023 | $-0.04 | 1,193.10% |
| 2022 | 0.00 | -94.26% |
| 2021 | $-0.05 | -8.51% |
| 2020 | $-0.06 | -23.23% |
| 2019 | $-0.07 | -62.42% |
| 2018 | $-0.19 | 118.13% |
| 2017 | $-0.09 | -9.12% |
| 2016 | $-0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -7,319.25% |
US
|
|
| $4.09 | -11,035.83% |
IE
|
|
| $9.45 | -25,367.38% |
US
|
|
| $2.37 | -6,436.90% |
US
|
|
| $1.77 | -4,832.62% |
US
|
Questions about IXensor Co., Ltd.'s earnings per share (EPS)
What is IXensor Co., Ltd.'s earnings per share (EPS)?
IXensor Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was IXensor Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, IXensor Co., Ltd.'s earnings per share (EPS) was $-0.04, compared with $-0.06 in 2024.
How has IXensor Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, IXensor Co., Ltd.'s earnings per share (EPS) was highest in 2022 (0.00) and lowest in 2024 ($-0.06).
How does IXensor Co., Ltd.'s earnings per share (EPS) compare with similar companies?
IXensor Co., Ltd.'s earnings per share (EPS) ($-0.04) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.